MAPT and Cerebral ischemia: The results of in vivo study revealed that pretreatment with M. pruriens seed extract and its specific bioactive molecule, β-sitosterol improved neurological deficit score, decreased ischemic brain damage and reduced the gene expression of NMDAR and tau protein in cerebral ischemia induced by LCCAO in experimental animals.